23/10/2025
Greetings from CHCC
We understand and share your frustrations with the ongoing ARV shortages affecting local supplies. The good news is, we managed to secure a temporary substitute while global supply chain issues are being resolved.
As we cannot predict the months ahead, please be prepared for possible changes in treatment options should the tides shift again. For now, Efavirenz-based medications (such as TRUSTIVA, VIRADAY and MACTRIVIR) remain limited nationwide, and are expected to last until the end of 2025 or longer.
In the meantime, CHCC will be providing a 2-pill regimen consisting of TENOHOPE/ TENOF-EM (TDF/FTC) and ESTIVA/VIRANZ/EFAMAT (EFV) both containing the same active ingredients as previously sold brand-names and are equally as effective
Please do not ration your medication as this can be harmful.
If you have concerns, we gently urge you to book a consultation with our doctors.
New patients must present a valid hardcopy prescription from their healthcare provider.
For appointments or inquiries, contact us on WhatsApp at +601121434572.
We deeply appreciate your patience and trust as we work to prioritise your treatment and care ❤️🩹